NEW YORK (Reuters) - CVS Health Corp CVS.N on Thursday said that a request for more information from U.S. antitrust regulators reviewing its proposed $69 billion acquisition of health insurer Aetna Inc AET.N does not impact its expectation that the deal will close in the second half of 2018.
The companies said on Feb. 1 that they had been contacted by the U.S. Department of Justice for additional information. The companies have a shareholder meeting scheduled for March 20 to vote on the transaction.
Reporting by Caroline HumerEditing by Chizu Nomiyama
Our Standards: The Thomson Reuters Trust Principles.